Influenza vaccine and survival in acute heart failure

European Journal of Heart Failure

Volumn 16, Issue 3, 2014, Pages 264-270

  Kopel, Eran ^a   Klempfner, Robert ^a   Goldenberg, Ilan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Congestive heart failure; Epidemiology; Influenza vaccine; Medical surveillance bias; Prospective cohort; Selection bias; Unmeasured confounding

Indexed keywords

INFLUENZA VACCINE;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROPENSITY SCORE; SEASONAL INFLUENZA; SOCIAL STATUS; SURVIVAL; VERY ELDERLY;

CONGESTIVE HEART FAILURE; EPIDEMIOLOGY; INFLUENZA VACCINE; MEDICAL SURVEILLANCE BIAS; PROSPECTIVE COHORT; SELECTION BIAS; UNMEASURED CONFOUNDING;

ACUTE DISEASE; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; ISRAEL; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; SELECTION BIAS; SURVIVAL ANALYSIS;

EID: 84897012205     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.14     Document Type: Article

References (26)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-1847.
2. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM, American Heart Association, American College of Cardiology. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006;114:1549-1553.
3. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-3045.
4. Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, Thompson WW, Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002;156:634-640.
5. Gurfinkel EP, De La Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002;105:2143-2147.
6. Gurfinkel EP, Leon De La Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004;25:25-31.
7. Keller T, Weeda VB, Van Dongen CJ, Levi M. Influenza vaccines for preventing coronary heart disease. Cochrane Database Syst Rev 2008;3: CD005050.
8. Garty M, Shotan A, Gottlieb S, Mittelman M, Porath A, Lewis BS, Grossman E, Behar S, Leor J, Green MS, Zimlichman R, Caspi A, HFSIS Steering Committee and Investigators. The management, early and one year outcome in hospitalized patients with heart failure: a national Heart Failure Survey in Israel - HFSIS 2003. Isr Med Assoc J 2007;9:227-233.
9. Lewis BS, Shotan A, Gottlieb S, Behar S, Halon DA, Boyko V, Leor J, Grossman E, Zimlichman R, Porath A, Mittelman M, Caspi A, Garty M, HFSIS Investigators. Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. Isr Med Assoc J 2007;9:234-238.
10. Barsheshet A, Garty M, Grossman E, Sandach A, Lewis BS, Gottlieb S, Shotan A, Behar S, Caspi A, Schwartz R, Tenenbaum A, Leor J. Admission blood glucose level and mortality among hospitalized nondiabetic patients with heart failure. Arch Intern Med 2006;166:1613-1619.
11. Barsheshet A, Shotan A, Cohen E, Garty M, Goldenberg I, Sandach A, Behar S, Zimlichman E, Lewis BS, Gottlieb S, HFSIS Steering Committee and Investigators. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail 2010;12:833-840.
12. Israel Central Bureau of Statistics. Health survey 2009. http://www.cbs.gov. il/reader/?MIval=cw-usr-view-SHTML&ID=598.
13. Centers for Disease Control and Prevention (CDC). About the BRFSS: turning information into public health. http://www.cdc.gov/brfss/about.htm (21 April 2012).
14. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, GA: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2003-2004.
15. Centers for Disease Control and Prevention (CDC). BRFSS summary data quality report. 2003. ftp://ftp.cdc.gov/pub/data/brfss/2003SummaryDataQuality Report.pdf (21 April 2012).
16. Centers for Disease Control and Prevention (CDC). BRFSS summary data quality report. 2004. ftp://ftp.cdc.gov/pub/data/brfss/ 2004SummaryDataQualityReport.pdf (21 April 2012).
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
18. Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2010;55:648-659.
19. Joffe MM, Rosenbaum PR. Propensity scores. Am J Epidemiol 1999;150:327-333.
20. Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;29:1350-1358.
21. Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011;32:1730-1735.
22. De Diego C, Vila-Córcoles A, Ochoa O, Rodriguez-Blanco T, Salsench E, Hospital I, Bejarano F, Del Puy Muniain M, Fortin M, Canals M, EPIVAC Study Group. Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease. Eur Heart J 2009;30:209-216.
23. Van Ermen A, Hermanson MP, Moran JM, Sweitzer NK, Johnson MR, Vardeny O. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study. Eur J Heart Fail 2013;15:560-564.
24. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010;2: CD004876.
25. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010;7: CD001269.
26. Wong K, Campitelli MA, Stukel TA, Kwong JC. Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method. Arch Intern Med 2012;172:484-491.